CASP3 and Epstein-Barr virus infection: The levels of miRNA used in this proof-of-principle experiment are probably not physiologically attainable, but others have documented the effect of EBV miRNA expression on CASP3 protein levels and downstream effects on its substrate PARP (a measure of CASP3 activity) in both B cells and epithelial cells that are models for EBV infection.